WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for ...

TScan Therapeutics' stock rises after announcing a $30 million financing deal with Lynx1, extending its cash runway into 2027 ...

Clinical-stage biotechnology company TScan Therapeutics, Inc. (TCRX) Thursday announced that it has entered into a securities ...

TScan Therapeutics shares jumped 23% in premarket trading after a $30 million registered direct offering. Shares were trading around $3.58. The stock is down about 50% on the year.

Additional information about the reverse stock split can be found in Optinose's Definitive Proxy Statement filed with the Securities and Exchange Commission ("SEC”) on December 12, 2024. The Proxy ...

The main opposition Democratic Party (DP) submitted an impeachment motion against acting President Han Duck-soo and reported it to a parliamentary plenary session Thursday. The ... The ...

A 10 year old Thai boy tragically died after an old rusty football goal crossbar fatally struck him on the head at his school in the Wichit sub-district of Phuket . Facebook page Phuket Info Center ...